Detemir: Role in Type 1 Diabetes

Completed · Phase 4

Conditions studied: Type 1 Diabetes Mellitus

In brief

Study of blood sugars in the children with Type 1 Diabetes Mellitus (T1DM), who are given insulin detemir and a rapid acting insulin (aspart). It is hypothesized that there is no difference in the patterns of blood sugars when detemir is given in the same syringe or in separate syringes with rapid acting insulin.

Key facts

Study ID

NCT00564395

Run by

Montefiore Medical Center

People needed

18

Starts

2007-08-01

Expected to finish

2010-05-01

Last updated by the study team

2018-07-17

Who can join

Age: 10 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with antibody positive Type 1 Diabetes Mellitus (T1DM)
• On insulin glargine for at least 3 months
• Age 10-25 years
• Not on medications that may affect glucose concentrations
• Hemoglobin A1C (HbA1C) of less than 9 %
• Body Mass Index (BMI) less than 95th % and more than 10th%
• Supportive family

You may not qualify if…

• Subjects with undetermined diabetes or Type 2 Diabetes Mellitus (T2DM)
• Unable to adhere to insulin regimen
• Positive urine pregnancy test

Where it is running

• Texas Children's Hospital Endocrine and Diabetes Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.